Literature DB >> 18368475

The decrease of serum luteinizing hormone level by a gonadotropin-releasing hormone antagonist following the mild IVF stimulation protocol for IVF and its clinical outcome.

Atsushi Yanaihara1, Takeshi Yorimitsu, Hiroshi Motoyama, Motohiro Ohara, Toshihiro Kawamura.   

Abstract

PURPOSE: While performing the mild ovarian stimulation protocol with a GnRH antagonist, the pregnancy rate was compared between the groups, which were divided by the degree that the luteinizing hormone (LH) level decreased.
MATERIALS AND METHODS: Patients aged 27 to 42years (36.1 +/- 3.79) underwent 308 IVF cycles who opted for IVF via the mild ovarian stimulation protocol began clomiphene citrate on day 3 and recombinant FSH on day 5. A GnRH antagonist was administered when the dominant follicle reached 14mm. Serum LH was measured at the time of GnRH antagonist administration and at the time of hCG injection. The pregnancy rate and implantation rate were compared between 50 cycles in which the LH level dropped less than one-third and the control (LH level within 1/3). RESULT(S): The pregnancy rate for the group in which the LH level fell less than one third was 18%. Conversely, the pregnancy rate for the control group was 39%. The implantation rate was 18% for the less than one-third group and 26% for the control group. Both the pregnancy rate and the implantation rate for the group in which the LH level fell less than one-third were significantly lower than that of control (p < 0.02). CONCLUSION(S): When performing the mild ovarian stimulation protocol, serum LH should be followed. If the serum LH level is less than one-third at the time of hCG injection, both the pregnancy rate and implantation rate are significantly lower.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18368475      PMCID: PMC2582073          DOI: 10.1007/s10815-008-9205-6

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  21 in total

1.  Minimal ovarian hyperstimulation for in vitro fertilization using sequential clomiphene citrate and gonadotropin with or without the addition of a gonadotropin-releasing hormone antagonist.

Authors:  Shaun C Williams; William E Gibbons; Suheil J Muasher; Sergio Oehninger
Journal:  Fertil Steril       Date:  2002-11       Impact factor: 7.329

2.  Inhibition of luteinizing hormone receptor expression during the development of caprine corpora lutea by administration of gonadotropin-releasing hormone antagonist.

Authors:  Noritoshi Kawate; Makoto Tsuji; Hiromichi Tamada; Toshio Inaba; Tsutomu Sawada
Journal:  Mol Reprod Dev       Date:  2002-12       Impact factor: 2.609

3.  Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group.

Authors:  C Albano; R E Felberbaum; J Smitz; H Riethmüller-Winzen; J Engel; K Diedrich; P Devroey
Journal:  Hum Reprod       Date:  2000-03       Impact factor: 6.918

4.  Evidence for cycle-dependent expression of full-length human chorionic gonadotropin/luteinizing hormone receptor mRNA in human endometrium and decidua.

Authors:  Peter Licht; Michael von Wolff; Alexander Berkholz; Ludwig Wildt
Journal:  Fertil Steril       Date:  2003-03       Impact factor: 7.329

5.  Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders.

Authors:  N Nikolettos; S Al-Hasani; R Felberbaum; L C Demirel; W Kupker; P Montzka; Y X Xia; B Schopper; R Sturm; K Diedrich
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2001-08       Impact factor: 2.435

6.  Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist.

Authors:  Asimina Tavaniotou; Carola Albano; Johan Smitz; Paul Devroey
Journal:  Fertil Steril       Date:  2002-04       Impact factor: 7.329

7.  Luteinizing hormone affects uterine receptivity independently of ovarian function.

Authors:  Jan Tesarik; André Hazout; Carmen Mendoza
Journal:  Reprod Biomed Online       Date:  2003 Jul-Aug       Impact factor: 3.828

8.  Comparison of stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and recombinant luteinizing hormone to stimulation with a gonadotropin-releasing hormone agonist protocol: a prospective, randomized study.

Authors:  Monika Weigert; Ursula Krischker; Michaela Pöhl; Gunda Poschalko; Christoph Kindermann; Wilfried Feichtinger
Journal:  Fertil Steril       Date:  2002-07       Impact factor: 7.329

9.  A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.

Authors:  Femke P Hohmann; Nicholas S Macklon; Bart C J M Fauser
Journal:  J Clin Endocrinol Metab       Date:  2003-01       Impact factor: 5.958

10.  Ovarian stimulation by clomiphene citrate and hMG in combination with cetrorelix acetate for ICSI cycles.

Authors:  Jiann-Loung Hwang; Lee-Wen Huang; Bih-Chwen Hsieh; Yieh-Loong Tsai; Shih-Chia Huang; Chin-Yu Chen; Mei-Ling Hsieh; Pei-Hsin Chen; Yu-Hung Lin
Journal:  Hum Reprod       Date:  2003-01       Impact factor: 6.918

View more
  6 in total

1.  Outcome of in vitro fertilization in patients with proven poor ovarian responsiveness after early vs. mid-follicular LH exposure: a prospective, randomized, controlled study.

Authors:  Alberto Revelli; Alessandra Chiado'; Daniela Guidetti; Francesca Bongioanni; Valentina Rovei; Gianluca Gennarelli
Journal:  J Assist Reprod Genet       Date:  2012-05-29       Impact factor: 3.412

2.  "Mild" vs. "long" protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertilization (IVF): a large prospective randomized trial.

Authors:  Alberto Revelli; Alessandra Chiadò; Paola Dalmasso; Veronica Stabile; Francesca Evangelista; Gemma Basso; Chiara Benedetto
Journal:  J Assist Reprod Genet       Date:  2014-04-04       Impact factor: 3.412

Review 3.  Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization.

Authors:  Alberto Revelli; Simona Casano; Francesca Salvagno; Luisa Delle Piane
Journal:  Reprod Biol Endocrinol       Date:  2011-02-16       Impact factor: 5.211

4.  Difference in the size of the placenta and umbilical cord between women with natural pregnancy and those with IVF pregnancy.

Authors:  Atsushi Yanaihara; Shota Hatakeyama; Shirei Ohgi; Kenichirou Motomura; Ryoma Taniguchi; Aguri Hirano; Shin Takenaka; Takumi Yanaihara
Journal:  J Assist Reprod Genet       Date:  2017-11-14       Impact factor: 3.412

5.  Is there a relationship between luteinizing hormone levels and ART outcome in GnRH antagonist protocols? A retrospective cross-sectional study.

Authors:  Maryam Eftekhar; Masrooreh Hoseini; Nasim Tabibnejad
Journal:  Indian J Endocrinol Metab       Date:  2022-02-17

Review 6.  Dichorionic triplets following frozen-thawed poor-stage embryo transfer: a report of two cases and a review.

Authors:  Atsushi Yanaihara; Shirei Ohgi; Kenichirou Motomura; Ryoma Taniguchi; Shota Hatakeyama; Takumi Yanaihara
Journal:  Reprod Biol Endocrinol       Date:  2017-10-03       Impact factor: 5.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.